Advertisement
Through its 'Dynamic Screening' process, Soar's proprietary analytics technology helps men with elevated PSA scores and their doctors by providing users with simple access to a rigorous analysis of a patient's test results and medical history. This medical data is compared against tens of thousands of cases that can help the patient and doctor quickly narrow in on a personalized approach to care.
Advertisement
"Soar BioDynamics brings game-changing evidence-based analysis to help men and their doctors cut through the controversy and information overload," said CEO and Chief Scientist Tom Neville, Ph.D. "The Cancer Probability Report is easy to understand and helps bring context to PSA scores, allowing doctors to apply best practices that lead to better outcomes."
Other enhanced resources on the Web site include:
How the Dynamic Screening Process Works
Patients enter their medical information on www.SoarBioDynamics.com and receive via email their Cancer Probability Report, a personalized analysis with a cancer probability scenario and recommended action paths. Soar Dynamic Screening uses research-based mathematical analysis to augment existing information by trending patients' individual blood test results and other factors over time and comparing them to those of representative populations. As a result, Soar Dynamic Screening aids in the identification of early indications of prostatitis, BPH and cancer. This analysis may be used to reduce the risk of false positive biopsy results, recurrence of cancer after initial treatment and discovery of indolent cancer when compared to conventional screening. Users can now select to receive their Cancer Probability Report as a short easy-to-read summary or a more detailed analysis.
About Soar BioDynamics, Ltd.
Soar BioDynamics harnesses the power of advanced mathematical computation to bring bold new perspective to common medical test results with an easy-to-use Web-based system. Dynamic Screening for prostate cancer is Soar's first invention that has been expanded to screening for prostatitis and BPH. Soar's Cancer Probability Report can help bring context to PSA test results and help patients and doctors make more enlightened choices about further tests, referrals or treatments.
For more information regarding Soar BioDynamics, Ltd. or to view a sample report, please visit http://www.SoarBioDynamics.com.
-- Elevated PSA? Provides patients concerned about abnormal PSA scores with a clear guide to the issues surrounding prostate screening tests. On the page, visitors can walk through what an elevated PSA score means, the problem of overtreatment and how to use Soar BioDynamics Screening with doctors. -- Why Screen? Gives information about the prevalence of prostate cancer and an overview of the controversies surrounding screening tests. -- About Soar BioDynamics: Discusses Soar's Dynamic Screening that synthesizes best practices validated by the latest peer-reviewed medical research for more reliable detection. -- Dynamic Screening: Offers additional resources such as a glossary of medical terms, frequently asked questions and a page for physicians, with data points, research and links to leading medical centers using dynamic screening best practices.
SOURCE Soar BioDynamics, Ltd.
